Thrombin generation assay and lupus anticoagulant synergically distinguish populations of patients with antiphospholipid antibodies
Conclusions
TGA seems a valuable approach to stratify aPL+ patients according to their risk profile. The differences among different populations of autoantibodies specificities could be considered a translational validation of the increased thrombotic risk of patients with triple or tetra aPL-positivity.
Source: Journal of Clinical Pathology - Category: Pathology Authors: Radin, M., Barinotti, A., Cecchi, I., Foddai, S. G., Rubini, E., Roccatello, D., Menegatti, E., Sciascia, S. Tags: Original research Source Type: research
More News: Antiphospholipid Syndrome | Cardiology | Heart | Hughes Syndrome | Lupus | Men | Pathology | Peripheral Vascular Disease (PVD) | Vitamin K | Vitamins